Navigation Links
Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposium™
Date:2/17/2011

BOCA RATON, Fla., Feb. 17, 2011 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 9th Annual South Beach Symposium™ in Miami Beach, FL on February 17-21, 2011.  The South Beach Symposium™ is a comprehensive session with three non-overlapping tracks in clinical dermatology, aesthetics, and practice management. Sensus Healthcare is featuring superficial radiotherapy (SRT) with their SRT-100™ advanced platform as a complimentary tool for the dermatologists and Mohs surgeons and as a non-surgical option for their patients. Dr. Gary D. Monheit is a keynote speaker at the symposium, reviewing the advantages of SRT and its pertinence and benefits to the dermatology practices and non-melanoma skin cancer patients, with a presentation titled "Radiation Therapy in the Treatment of Skin Cancer: Back Home to Dermatology" on Sunday February 20, 2011 at 9:00AM Eastern. Visit Sensus (booth #416) at the 9th South Beach Symposium™ to be held at the Loews Miami Beach Hotel to learn about the SRT-100™ low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy solution.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO)

"Sensus is very excited to be participating in this year's South Beach Symposium. We are looking forward to meeting with key leaders of Dermatology as we present the SRT-100™ as a compliment to their existing array of skin cancer treatments" –Steve Cohen (Vice President of Strategic Initiatives, Sensus Healthcare)

About Sensus Healthcare:Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.

About South Beach Symposium™:The South Beach Symposium is designed to meet the needs of physicians, nurses and professional staff members of medical practices specializing in dermatology, plastic surgery, cosmetic surgery, pediatric dermatology and other dermatologic medical procedures. The symposium features three non–overlapping CME tracks – the South Beach Clinical Dermatology Symposium, the South Beach Aesthetics Symposium and the Practice Management Symposium.Contact:Vicky PerezPublic Relations561-922-5808 Ext 108vicky@sensushealthcare.com
'/>"/>

SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sensus Healthcare Announces the Formation of a Medical Advisory Board
2. Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
3. Sensus Healthcare Announces Strategic Partnership With Flagship Solutions Group
4. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
5. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
6. New consensus on work-related asthma
7. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
8. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
10. Orexigen® Therapeutics to Present at JP Morgan Healthcare Conference
11. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 19, 2017 AquaBounty Technologies, Inc. (AIM: ... productivity in aquaculture and a majority-owned subsidiary of Intrexon ... has completed the listing of its common shares on ... from Intrexon. "AquaBounty,s listing on NASDAQ represents ... our exposure to the U.S. markets as we advance ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... ... 19, 2017 , ... DaVita Clinical Research (DCR), ... and device development, and Prism Clinical Research , a leader in providing ... Verified Clinical Trials (VCT) has been selected by both companies as an ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... 2016   IdentyTechSolutions America LLC , a ... solutions and a cutting-edge manufacturer of software and ... offering seamless, integrated solutions that comprise IDT biometric ... solutions provide IdentyTech,s customers with combined physical identification ... crime and theft. "We are proud ...
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
Breaking Biology News(10 mins):